UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 423

Sortiert nach

A novel STING agonist-adjuvanted pan-sarbecovirus vaccine elicits potent and durable neutralizing antibody and T cell responses in mice, rabbits and NHPs

Cell research, 2022-03, Vol.32 (3), p.269-287

2022

Volltextzugriff (PDF)

Detection and Phenotyping of Circulating Tumor Cells in High-Risk Localized Prostate Cancer

Clinical genitourinary cancer, 2015-04, Vol.13 (2), p.130-136

2015

Volltextzugriff (PDF)

Blood-based gene expression signature associated with metastatic castrate-resistant prostate cancer patient response to abiraterone plus prednisone or enzalutamide

Prostate cancer and prostatic diseases, 2021-06, Vol.24 (2), p.448-456

2021

Volltextzugriff (PDF)

Mechanistic Investigation of the Androgen Receptor DNA-Binding Domain Inhibitor Pyrvinium

ACS omega, 2019-02, Vol.4 (2), p.2472-2481

2019

Volltextzugriff (PDF)

A microdosing approach for characterizing formation and repair of carboplatin–DNA monoadducts and chemoresistance

International journal of cancer, 2011-09, Vol.129 (6), p.1425-1434

2011

Volltextzugriff (PDF)

Vitamin K epoxide reductase expression and prostate cancer risk

Urologic oncology, 2017-03, Vol.35 (3), p.112.e13-112.e18

2017

Volltextzugriff (PDF)

Targeted Myocardial Hypoxia Imaging Using a Nitroreductase-Activatable Near-Infrared Fluorescent Nanoprobe

Analytical chemistry (Washington), 2019-05, Vol.91 (10), p.6585-6592

2019

Volltextzugriff (PDF)

Identification of mechanisms of resistance to treatment with abiraterone acetate or enzalutamide in patients with castration‐resistant prostate cancer (CRPC)

Cancer, 2018-03, Vol.124 (6), p.1216-1224

2018

Volltextzugriff (PDF)

Targeted Myocardial Hypoxia Imaging Using a Nitroreductase-Activatable Near-Infrared Fluorescent Nanoprobe

Analytical chemistry (Washington), 2019-05, Vol.91 (10), p.6585

2019

Volltextzugriff (PDF)

Ligand-Independent and Tissue-Selective Androgen Receptor Inhibition by Pyrvinium

ACS chemical biology, 2014-03, Vol.9 (3), p.692-702

2014

Volltextzugriff (PDF)

Vitamin K epoxide reductase regulation of androgen receptor activity

Oncotarget, 2017-02, Vol.8 (8), p.13818-13831

2017

Volltextzugriff (PDF)

RNA-seq reveals aurora kinase-driven mTOR pathway activation in patients with sarcomatoid metastatic renal cell carcinoma

Molecular cancer research, 2015-01, Vol.13 (1), p.130-137

2015

Volltextzugriff (PDF)

Synaptophysin expression on circulating tumor cells in patients with castration resistant prostate cancer undergoing treatment with abiraterone acetate or enzalutamide

Urologic oncology, 2018-04, Vol.36 (4), p.162.e1-162.e6

2018

Volltextzugriff (PDF)

Low Testosterone Alters the Activity of Mouse Prostate Stem Cells

The Prostate, 2017-04, Vol.77 (5), p.530-541

2017

Volltextzugriff (PDF)

Low systemic testosterone levels induce androgen maintenance in benign rat prostate tissue

Journal of molecular endocrinology, 2013-08, Vol.51 (1), p.143-153

2013

Volltextzugriff (PDF)

Abstract 375: Phenotypic and molecular characterization of circulating tumor cells (CTCs) in patients with castration resistant prostate cancer (CRPC) undergoing treatment with abiraterone acetate or enzalutamide

Cancer research (Chicago, Ill.), 2015-08, Vol.75 (15_Supplement), p.375-375

2015

Volltextzugriff (PDF)

Comparison VEGF-pathway elements and EMT markers in patients with sarcomatoid metastatic renal cell carcinoma and risk-matched controls

Journal of clinical oncology, 2014-05, Vol.32 (15_suppl), p.e15613-e15613

2014

Volltextzugriff (PDF)

Deep sequencing of sarcomatoid renal cell carcinoma (sRCC) and identification of aurora kinases and mTOR as potential therapeutic targets

Journal of clinical oncology, 2014-02, Vol.32 (4_suppl), p.411-411

2014

Volltextzugriff (PDF)

Tissue-Selective Regulation of Androgen-Responsive Genes

Endocrine research, 2012-11, Vol.37 (4), p.203-215

2012

Volltextzugriff (PDF)

2138 CIRCULATING TUMOR CELLS (CTCS) ARE DETECTABLE IN PATIENTS WITH HIGH-RISK, LOCALIZED PROSTATE CANCER THROUGH USE OF THE CELLSEARCH PLATFORM

The Journal of urology, 2013-04, Vol.189 (4), p.e875-e876

2013

Volltextzugriff (PDF)

Elevated pS6K levels in the sarcomatoid component of tumors derived from patients with metastatic renal cell carcinoma (mRCC)

Journal of clinical oncology, 2013-02, Vol.31 (6_suppl), p.475-475

2013

Volltextzugriff (PDF)

Detecting circulating tumor cells (CTCs) in patients with high-risk, localized prostate cancer using the CellSearch platform

Journal of clinical oncology, 2012-05, Vol.30 (15_suppl), p.e15178-e15178

2012

Volltextzugriff (PDF)

Abstract 1183: Phase 0 microdosing trial quantitating DNA adduct formation to identify platinum chemosensitivity: from bench to bedside

Cancer research (Chicago, Ill.), 2013-04, Vol.73 (8_Supplement), p.1183-1183

2013

Volltextzugriff (PDF)

Abstract 3522: A Phase 0 microdosing trial to identify chemoresistance: From bench to bedside

Cancer research (Chicago, Ill.), 2010-04, Vol.70 (8_Supplement), p.3522-3522

2010

Volltextzugriff (PDF)

GW28-e0648 The cardiac toxicity effects of anti-tumor drug vandetanib

Journal of the American College of Cardiology, 2017-10, Vol.70 (16), p.C23-C23

Li, Miaoling

2017

Volltextzugriff (PDF)

1 – 25 von 423

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(384)
Mit Volltextzugriff
(405)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(300)
Life Sciences & Biomedicine
(183)
Humans
(99)
Physical Sciences
(90)
Technology
(70)
Female
(56)
Male
(47)
Chemistry
(46)
Materials Science
(40)
Materials Science, Multidisciplinary
(35)
Physics
(35)
Animals
(34)
Engineering
(32)
Oncology
(31)
Science & Technology - Other Topics
(28)
Physics, Applied
(27)
Middle Aged
(25)
Ophthalmology
(25)
Environmental Sciences
(23)
Environmental Sciences & Ecology
(23)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

A novel STING agonist-adjuvanted pan-sarbecovirus vaccine elicits potent and durable neutralizing antibody and T cell responses in mice, rabbits and NHPs

Detection and Phenotyping of Circulating Tumor Cells in High-Risk Localized Prostate Cancer

Blood-based gene expression signature associated with metastatic castrate-resistant prostate cancer patient response to abiraterone plus prednisone or enzalutamide

Mechanistic Investigation of the Androgen Receptor DNA-Binding Domain Inhibitor Pyrvinium

A microdosing approach for characterizing formation and repair of carboplatin–DNA monoadducts and chemoresistance

Vitamin K epoxide reductase expression and prostate cancer risk

Targeted Myocardial Hypoxia Imaging Using a Nitroreductase-Activatable Near-Infrared Fluorescent Nanoprobe

Identification of mechanisms of resistance to treatment with abiraterone acetate or enzalutamide in patients with castration‐resistant prostate cancer (CRPC)

Targeted Myocardial Hypoxia Imaging Using a Nitroreductase-Activatable Near-Infrared Fluorescent Nanoprobe

Ligand-Independent and Tissue-Selective Androgen Receptor Inhibition by Pyrvinium

Vitamin K epoxide reductase regulation of androgen receptor activity

RNA-seq reveals aurora kinase-driven mTOR pathway activation in patients with sarcomatoid metastatic renal cell carcinoma

Synaptophysin expression on circulating tumor cells in patients with castration resistant prostate cancer undergoing treatment with abiraterone acetate or enzalutamide

Low Testosterone Alters the Activity of Mouse Prostate Stem Cells

Low systemic testosterone levels induce androgen maintenance in benign rat prostate tissue

Abstract 375: Phenotypic and molecular characterization of circulating tumor cells (CTCs) in patients with castration resistant prostate cancer (CRPC) undergoing treatment with abiraterone acetate or enzalutamide

Comparison VEGF-pathway elements and EMT markers in patients with sarcomatoid metastatic renal cell carcinoma and risk-matched controls

Deep sequencing of sarcomatoid renal cell carcinoma (sRCC) and identification of aurora kinases and mTOR as potential therapeutic targets

Tissue-Selective Regulation of Androgen-Responsive Genes

2138 CIRCULATING TUMOR CELLS (CTCS) ARE DETECTABLE IN PATIENTS WITH HIGH-RISK, LOCALIZED PROSTATE CANCER THROUGH USE OF THE CELLSEARCH PLATFORM

Elevated pS6K levels in the sarcomatoid component of tumors derived from patients with metastatic renal cell carcinoma (mRCC)

Detecting circulating tumor cells (CTCs) in patients with high-risk, localized prostate cancer using the CellSearch platform

Abstract 1183: Phase 0 microdosing trial quantitating DNA adduct formation to identify platinum chemosensitivity: from bench to bedside

Abstract 3522: A Phase 0 microdosing trial to identify chemoresistance: From bench to bedside

GW28-e0648 The cardiac toxicity effects of anti-tumor drug vandetanib

Suchergebnisse filtern